Antonio Lahera
5PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 09, 2026
Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Jul 20, 2024
PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Sep 15, 2023
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Jun 02, 2023
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.Antonio Lahera, Laura Vela-Martín, Pilar López-Nieva
|Feb 14, 2023
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.Antonio Lahera, Pilar López-Nieva, Hernán Alarcón
Pageof 1
Frequent Collaborators
5 joint publications
María Villa-Morales
4 joint publications
José Fernández-Piqueras
3 joint publications
Laura Vela-Martín
3 joint publications
José L López-Lorenzo
2 joint publications
Pilar López-Nieva
2 joint publications
Pablo Fernández-Navarro
2 joint publications
Isabel Sastre
2 joint publications
Javier Cornago
2 joint publications
Javier Santos
1 joint publications
Manuel Fresno
